studi
object
littl
known
natur
recoveri
period
sever
acut
respiratori
syndrom
sar
infect
hypothes
structur
chang
lung
might
correl
symptom
pulmonari
function
answer
question
correl
find
highresolut
ct
hrct
dyspnea
score
result
pulmonari
function
test
patient
recoveri
sar
design
retrospect
followup
cohort
studi
set
univers
hospit
patient
nineteen
patient
recov
sarsrel
hospit
measur
studi
includ
hrct
score
dyspnea
score
static
dynam
lung
volum
diffus
capac
lung
carbon
monoxid
dlco
result
interv
hospit
discharg
hrct
studi
function
assess
day
rang
day
mean
sd
patient
hrct
abnorm
assign
two
group
groundglass
opac
ggo
n
ggo
fibrosi
n
patient
zonal
predomin
hrct
score
correl
well
dyspnea
score
r
p
varieti
pulmonari
function
variabl
dlco
signific
r
p
compar
ggo
group
group
show
significantli
lower
fev
fvc
total
lung
capac
residu
volum
dlco
conclus
hrct
find
correl
well
function
studi
clinic
symptom
recoveri
sar
longerterm
followup
studi
larger
cohort
patient
perform
investig
clinic
outcom
recov
sar
patient
chest
us
center
diseas
control
prevent
cdc
criteria
hospit
die
clinic
radiolog
investig
find
initi
present
progress
sar
describ
previous
date
investig
outcom
patient
recoveri
stage
focus
persist
respiratori
symptom
limit
among
recent
report
antonio
et
al
describ
fibrosi
present
symptomat
patient
sar
discharg
suggest
fibrosi
like
develop
patient
sever
diseas
howev
extent
diseas
evalu
ct
relationship
function
studi
symptom
patient
recoveri
sar
yet
report
therefor
import
comprehens
insight
possibl
clinic
outcom
patient
sar
recoveri
period
enabl
identif
patient
recov
expect
rate
hypothes
structur
chang
detect
highresolut
ct
hrct
might
correl
symptom
pulmonari
function
retrospect
studi
perform
examin
relationship
among
hrct
find
pulmonari
symptom
lung
function
patient
persist
pulmonari
symptom
earli
recoveri
sar
june
juli
patient
sar
met
specifi
discharg
criteria
discharg
hospit
diagnosi
lead
origin
hospit
establish
base
cdc
definit
sar
review
medic
record
discharg
patient
sar
identifi
patient
exhibit
dyspnea
strenuou
activ
patient
remain
symptomat
extent
underw
hrct
pulmonari
function
test
pft
part
clinic
evalu
patient
symptomat
could
scan
clinic
purpos
nation
insur
polici
would
pay
scan
along
hrct
scan
patient
underw
pft
followup
evalu
variou
degre
persist
respiratori
symptom
form
basi
studi
patient
subject
respiratori
complaint
diagnos
probabl
case
sar
patient
base
cdc
criteria
confirm
posit
revers
transcriptasepolymeras
chain
reaction
rtpcr
test
result
sarsassoci
coronaviru
sarscov
either
follow
sampl
throat
swab
serum
urin
collect
patient
sampl
sar
patient
institut
sent
cdc
taiwan
rtpcr
perform
use
protocol
describ
report
hsueh
et
al
adjunct
confirm
diagnosi
igg
antibodi
sarscov
detect
standard
indirect
fluoresc
antibodi
assay
titer
serum
use
test
sampl
laboratori
work
develop
later
rtpcr
cdc
taiwan
appli
patient
among
patient
undergo
test
posit
result
hrct
examin
perform
somatom
plu
ct
scanner
siemen
erlangen
germani
scan
paramet
follow
collim
kilovolt
peak
scan
time
field
view
imag
reconstruct
highspatialresolut
algorithm
parenchym
analysi
scan
obtain
suspend
endinspiratori
volum
patient
scan
supin
posit
addit
scan
obtain
prone
posit
avoid
physiologicdepend
area
attenu
posterior
lung
ct
scan
review
studi
two
radiolog
specialist
hhh
wcc
awar
ident
patient
clinic
find
individu
section
hrct
scan
assess
presenc
distribut
extent
pulmonari
abnorm
groundglass
opac
ggo
airspac
consolid
fibrosi
find
irregular
linear
opac
parenchym
band
irregular
interfac
lung
distort
traction
bronchiectasi
consid
reflect
fibrosi
distribut
find
classifi
follow
predominantli
upper
middl
lower
lung
zone
random
predominantli
peripher
peribronchovascular
random
patchi
diffus
random
anatom
distribut
note
peripher
predomin
abnorm
outer
third
lung
peribronchovascular
abnorm
close
relationship
bronchovascular
bundl
random
abnorm
clearli
fit
either
categori
employ
score
method
similar
one
describ
previous
extent
involv
assess
three
lung
zone
correspond
approxim
one
third
imag
lung
apex
cm
dome
diaphragm
ct
score
upper
middl
lower
lung
zone
determin
visual
estim
extent
diseas
zone
score
repres
percentag
lung
parenchyma
show
evid
abnorm
mainli
area
ggo
fibrosi
estim
nearest
parenchym
involv
overal
percentag
involv
obtain
averag
six
lung
zone
individu
observ
reproduc
intraobserv
variabl
hrct
score
determin
correl
read
imag
twice
two
individu
observ
awar
clinic
inform
final
score
determin
averag
score
assess
two
observ
differ
within
read
repeat
differ
score
two
observ
exceed
consensu
reach
review
degre
short
breath
describ
medic
record
grade
differ
score
accord
descript
stapl
et
al
dyspnea
score
grade
dyspnea
strenuou
activ
climb
three
flight
stair
heavi
housework
dyspnea
mild
activ
climb
one
flight
stair
light
housework
dyspnea
minim
activ
walk
feet
dyspnea
rest
eat
talk
pft
perform
pulmonari
function
laboratori
use
standard
procedur
patient
sit
upright
posit
flow
volum
curv
observ
maxim
fvc
maneuv
accur
flow
volum
curv
obtain
coach
patient
spirometri
lung
volum
measur
use
jaeger
bodyscreen
iibodybox
jaeger
germani
masterlab
softwar
jaeger
follow
paramet
record
fev
fvc
largest
sum
fvc
use
analysi
ratio
fev
fvc
forc
expiratori
flow
fef
fvc
total
lung
capac
tlc
function
residu
capac
frc
diffus
capac
lung
carbon
monoxid
dlco
determin
singlebreath
carbon
monoxid
techniqu
use
infrar
analyz
model
sensormed
yorba
linda
ca
pearson
correl
test
use
determin
correl
two
read
hrct
score
observ
determin
reproduc
well
correl
hrct
score
pulmonari
function
measur
correl
dyspnea
hrct
score
examin
spearman
correl
test
oneway
analysi
varianc
use
compar
result
pft
dyspnea
score
differ
ct
pattern
patient
remain
symptomat
discharg
men
women
age
rang
year
mean
sd
age
year
patient
underw
hrct
scan
pft
day
followup
interv
rang
day
mean
sd
day
discharg
six
patient
progress
ard
patient
treat
therapeut
regimen
recommend
et
al
includ
patient
puls
steroid
ps
patient
nonpuls
steroid
np
demograph
clinic
data
includ
smoke
statu
inform
hrct
studi
summar
tabl
note
patient
progress
ard
longer
hospit
stay
ard
day
vs
day
respect
p
hrct
find
consist
bilater
patchi
area
ggo
alon
accompani
septal
thicken
fig
top
patient
associ
superimpos
area
fibrosi
fig
bottom
patient
base
abovedescrib
descript
classifi
patient
two
group
ggo
ggo
fibrosi
six
seven
patient
area
ggo
without
fibrosi
show
zonal
predomin
predomin
involv
middl
lung
zone
observ
one
patient
random
distribut
without
central
peripher
predomin
evid
five
patient
wherea
peripher
peribronchovascular
distribut
present
one
patient
group
fibrosi
predominantli
involv
three
lung
ps
male
np
male
np
femal
ye
ps
femal
ps
male
ps
femal
np
femal
ye
ps
femal
ps
femal
np
male
ye
ps
femal
ye
ps
patient
smoke
histori
current
smoker
time
becam
ill
hospit
discharg
hrct
scan
pft
dyspnea
score
correl
well
measur
panel
pulmonari
function
paramet
provid
valid
score
system
use
studi
fig
hrct
score
correl
well
dyspnea
score
r
p
variou
pulmonari
function
variabl
fig
result
mean
valu
measur
function
paramet
ggo
group
list
tabl
compar
ggo
group
group
show
significantli
lower
mean
valu
fev
fvc
tlc
rv
dlco
fig
sar
first
report
southern
china
novemb
spread
rapidli
mani
countri
world
late
juli
countri
affect
sar
report
cumul
total
case
sar
result
death
taiwan
outbreak
began
late
april
hospit
citi
taipei
soon
spread
throughout
whole
island
treat
patient
institut
taiwan
epidem
discharg
follow
hospit
recent
report
demonstr
ct
highli
sensit
imag
studi
diagnosi
sar
pattern
well
describ
acut
earli
recoveri
phase
date
investig
function
chang
might
correl
structur
chang
depict
ct
focus
experi
persist
respiratori
symptom
recoveri
sar
report
perform
retrospect
studi
correl
pulmonari
function
clinic
symptom
cohort
sar
patient
discharg
develop
comprehens
insight
clinic
outcom
earli
recoveri
phase
similar
result
report
antonio
et
al
patient
studi
repres
discharg
sar
patient
patient
studi
limit
investig
structur
chang
lung
hrct
symptomat
patient
sar
recoveri
would
interest
compar
symptomat
patient
asymptomat
patient
see
whether
symptomat
patient
sever
hrct
abnorm
asymptomat
patient
studi
major
find
hrct
bilater
patchi
area
ggo
without
fibrosi
find
gener
agreement
antonio
colleagu
similar
find
fibrosi
patient
identifi
fibrosi
half
patient
patient
difficult
know
mani
structur
chang
resolv
time
patient
evid
fibrosi
hrct
import
concomit
presenc
groundglass
opacif
clear
presum
area
groundglass
opacif
may
repres
either
residu
inflamm
may
resolv
may
evolv
fibrosi
time
address
specul
longer
term
followup
may
need
believ
pulmonari
fibrosi
observ
recoveri
phase
would
least
part
account
respiratori
symptom
compar
ct
find
predomin
lower
lobe
peripher
distribut
acut
phase
sar
report
wong
et
al
antonio
et
al
observ
gener
predomin
distribut
parenchym
abnorm
differ
pattern
ct
abnorm
suggest
either
structur
chang
relat
sar
evolv
time
underli
pathophysiolog
process
may
resolv
vari
rate
dyspnea
score
evalu
symptom
valid
good
correl
valu
pulmonari
function
paramet
furthermor
dyspnea
score
correl
well
hrct
score
indic
pronounc
symptom
may
attribut
extens
parenchym
involv
support
signific
correl
hrct
score
number
pulmonari
function
paramet
reflect
reliabl
sever
loss
function
lung
two
group
patient
identifi
base
hrct
find
ggo
studi
studi
antonio
et
al
suggest
predomin
featur
lung
injuri
diffus
alveolar
damag
vari
degre
fibrin
deposit
within
peripher
airway
conclud
lung
histolog
vari
accord
durat
ill
studi
case
time
cours
day
show
organ
phase
diffus
alveolar
damag
type
ii
pneumocyt
hyperplasia
ct
find
bronchiol
obliteran
organ
pneumonia
well
character
similar
sar
taken
togeth
result
previou
patholog
imag
studi
specul
possibl
small
airway
dysfunct
reflect
pulmonari
function
studi
may
attribut
possibl
presenc
small
airway
obstruct
within
area
ggo
addit
may
reflect
repair
process
accompani
parenchym
inflamm
vari
phase
sar
may
extens
form
sarsrel
lung
injuri
reflect
pronounc
function
impair
demonstr
lung
damag
sar
believ
associ
cytokin
storm
elicit
viral
antigen
sarscov
may
share
common
pathogenesi
acut
lung
injuri
part
system
inflammatori
respons
syndrom
need
corticosteroid
treat
sar
reflect
natur
sarsrel
lung
injuri
elicit
cytokin
storm
recent
report
ho
et
al
show
ps
therapi
appear
efficaci
equal
safe
steroid
regimen
compar
lowdos
np
acut
stage
sar
contrast
antonio
et
al
employ
standard
treatment
protocol
sar
adult
recommend
et
al
patient
treat
methylprednisolon
addit
use
ribavirin
broadspectrum
antibiot
diagnosi
sar
confirm
unlik
studi
report
ho
et
al
divid
regimen
corticosteroid
therapi
ps
np
begin
treatment
sar
administ
ps
clinic
condit
worsen
deterior
chest
radiograph
find
decreas
oxygen
satur
studi
patient
pronounc
hrct
abnorm
wors
pft
result
virtual
treat
ps
rapid
deterior
clinic
condit
therefor
difficult
determin
whether
ps
therapi
efficaci
np
base
result
prospect
random
trial
longterm
followup
structur
function
chang
lung
need
determin
whether
ps
inde
superior
np
treat
patient
sar
recent
report
shown
approxim
patient
sar
progress
ard
ard
reflect
sever
form
sar
lead
mortal
rate
similar
ard
patient
type
pneumonia
patient
sar
requir
critic
care
notabl
medic
respons
sarsrel
ard
extend
well
beyond
intens
care
ard
caus
etiolog
involv
overwhelm
public
health
issu
viral
pneumonia
usual
resolv
without
clinic
radiolog
sequela
wherea
sarsrel
respiratori
sequela
appear
quit
common
among
survivor
observ
us
other
intriguingli
followup
ct
scan
ard
survivor
sar
tend
limit
extent
usual
show
predomin
ventral
distribut
fibrosi
parenchym
opacif
wherea
pulmonari
abnorm
sarsrel
ard
appear
random
distribut
usual
extens
restrict
type
function
impair
decreas
dlco
ard
survivor
describ
previou
report
howev
neff
colleagu
report
recent
residu
combin
restrict
obstruct
type
function
impair
remain
common
survivor
sever
ard
treat
surgic
intens
unit
gener
lung
volum
spirometr
measur
return
normal
patient
time
dlco
remain
low
longterm
followup
result
suggest
persist
decreas
dlco
reflect
perman
parenchym
damag
lung
fibrosi
ard
patient
similarli
evalu
sarsrel
function
chang
earli
recoveri
phase
show
restrict
defect
significantli
decreas
dlco
would
interest
compar
structur
function
chang
survivor
sarsrel
ard
late
recoveri
ard
survivor
relat
sar
similar
followup
protocol
combin
correl
studi
ct
clinic
function
paramet
patient
recoveri
sar
studi
demonstr
hrct
analysi
correl
well
function
studi
clinic
symptom
signific
correl
dlco
addit
patient
studi
show
restrict
function
impair
result
suggest
potenti
role
hrct
pulmonari
function
test
track
respiratori
sequela
relat
sar
longerdur
followup
studi
larger
cohort
patient
perform
investig
longterm
clinic
outcom
patient
recov
sar
